(AMD) Mycoplasma pneumoniae qPCR kit CE-IVD

CE-IVD marked qPCR kits for molecular diagnostics in oncology, infection detection, antimicrobial resistance, and genetic testing. Kits include all reagents with internal controls and are validated on multiple real-time PCR platforms. Assays designed to CDC and WHO standards offer high sensitivity and specificity with simplified setup and data analysis.

Regulatory-approved reverse transcription PCR kit meeting European In Vitro Diagnostic requirements. Suitable for clinical diagnostic applications in regulated markets.

CE-IVD certified digital PCR assay for rapid detection of key sepsis-causing pathogens including bacteria and fungi. Enables timely clinical decision-making in intensive care and emergency settings.

Sensitive and fast dPCR-based assay for detecting key sepsis-causing pathogens, enabling clinicians to make timely diagnostic decisions. CE-IVD certified for clinical use.

CE-IVD approved rapid reverse transcription PCR kit for detecting viral RNA in clinical samples. Provides accelerated results for infectious disease diagnosis.

CE-IVD certified dPCR assay for sensitive and rapid detection of key sepsis-causing pathogens, enabling timely clinical decision-making in critical care settings.

PCR-based nucleic acid test kit for rapid detection and identification of Mycoplasma pneumoniae in respiratory specimens. Uses fluorescence probe methodology for sensitive and specific diagnosis of mycoplasma respiratory infections. Designed for clinical laboratories and diagnostic centers to support respiratory pathogen identification and patient management.

Molecular diagnostic assay for Mycoplasma pneumoniae detection in respiratory infections. Provides accurate identification with high sensitivity and specificity.

An RT-PCR detection kit for identification of Mycoplasma pneumoniae nucleic acid in respiratory samples.

A diagnostic test kit for the detection of Mycoplasma pneumoniae using RNA isothermal amplification methodology. The kit supports respiratory infection screening and diagnosis in clinical laboratory applications.

In vitro diagnostic reagent that specifically detects and identifies Mycoplasma pneumoniae-derived DNA for rapid respiratory infection diagnosis in automated analyzer systems.

A diagnostic test kit for the detection of Mycoplasma pneumoniae nucleic acid using fluorescent PCR methodology. This kit is designed for respiratory infection diagnosis and identification in clinical laboratory settings.